Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Nephros (NEPH) Liabilities from Discontinued Operations (2021 - 2022)

Nephros has reported Liabilities from Discontinued Operations over the past 2 years, most recently at 130000.0 for Q3 2022.

Quarterly results put Liabilities from Discontinued Operations at 130000.0 for Q3 2022, changed N/A from a year ago — trailing twelve months through Sep 2022 was 130000.0 (changed N/A YoY), and the annual figure for FY2021 was 51000.0, changed.
Liabilities from Discontinued Operations for Q3 2022 was 130000.0 at Nephros, up from 51000.0 in the prior quarter.
Over the last five years, Liabilities from Discontinued Operations for NEPH hit a ceiling of 130000.0 in Q3 2022 and a floor of 51000.0 in Q4 2021.